Tesla To $175? Here Are 10 Other Price Target Changes For Friday

• Oppenheimer cut CarMax, Inc. KMX price target from $100 to $75. . Oppenheimer analyst Brian Nagel maintained an Outperform rating on the stock. CarMax shares fell 1.3% to $56.47 in pre-market trading.
• JP Morgan cut Paychex, Inc. PAYX price target from $121 to $119. JP Morgan analyst Tien-Tsin Huang maintained an Underweight rating on the stock. Paychex rose 2.1% to $114.48 in pre-market trading.
• Stephens & Co. slashed the price target on Mission Produce, Inc. AVO from $20 to $15. Stephens & Co. analyst Ben Bienvenu maintained an Overweight rating on the stock. Mission Produce shares fell 14.1% to $12.55 in pre-market trading.
• B. Riley Securities raised Cleveland-Cliffs Inc. CLF price target from $26 to $27. B. Riley Securities analyst Lucas Pipes maintained a Buy rating on the stock. Cleveland-Cliffs shares rose 0.6% to $17.02 in pre-market trading.
• Loop Capital cut Paramount Global PARA price target from $30 to $14. Loop Capital analyst Alan Gould downgraded the stock from Hold to Sell. Paramount Global shares fell 1.2% to $16.74 in pre-market trading.
• Needham cut Cytokinetics, Incorporated CYTK price target from $60 to $58. Needham analyst Serge Belanger maintained a Buy rating on the stock. Cytokinetics shares fell 3% to $46.01 in pre-market trading.
• Roth Capital raised Ligand Pharmaceuticals Incorporated LGND price target from $85 to $90. Roth Capital analyst Scott Henry maintained a Buy rating on the stock. Ligand Pharmaceuticals shares rose 2.7% to close at $67.03 on Thursday.
• Wedbush cut Tesla, Inc. TSLA price target from $250 to $175. Wedbush analyst Daniel Ives maintained an Outperform rating on the stock. Tesla shares rose 0.9% to $126.41 in pre-market trading.
• Raymond James raised ProQR Therapeutics N.V. PRQR price target from $2 to $5. Raymond James analyst Steven Seedhouse maintained an Outperform rating on the stock. ProQR Therapeutics shares fell 4.4% to $2.58 in pre-market trading.
• B of A Securities cut Rocket Pharmaceuticals, Inc. RCKT price target from $38 to $35. B of A Securities analyst Greg Harrison maintained a Buy rating on the stock. Rocket Pharmaceuticals shares fell 0.9% to $19.02 in pre-market trading.
• Needham cut VIZIO Holding Corp. VZIO price target from $16 to $11. Needham analyst Laura Martin maintained a Buy rating on the stock. VIZIO Holding shares rose 4.2% to $8.28 in pre-market trading.

Check This Out: Most Affordable Stocks In The Consumer Discretionary Sector: Tesla, Ford And More